Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Aug 31, 2020 5:28pm
127 Views
Post# 31481207

RE:RE:RE:RE:Sell orders pulled

RE:RE:RE:RE:Sell orders pulledCZO's current market cap is about $65M. This is a nano-cap (people consider microcaps to have a starting capitalizatioin of $300 or $500M) and instiutions / funds are restricted from purchasing shares.  At most a micro-cap fund may be able to nibble for a position.  Instiutions may be aware of the company but unlikely able to make any purchases. 

I currently own a company with a market cap of $400M but hear that until they reach $500M or have a share price of $5, or get a sensior TSX listing (perhaps even a combination of the 2), some funds cannot buy the stock. They are in the wings waiting.

This is where we as retail investors are nimble and not being held by these rules are able to buy cheap nano-microcaps.  It's one area where the playing field favors us, take advantage of it.  At this level we are playing against each other, retail against retail investor.

upside80 wrote: And realistically ZoranSto, they're already selling to J&J and Symrise is redistributing, there's no way institutional players aren't in the know and haven't already been engaged, if they haven't it's gross imcompetence on Gilles side, which I don't think is likely, patience will pay off here. 

They will however want a piece of the pie, so having them involved in financing a PGX deal will be important to greasing the money wheel. 


<< Previous
Bullboard Posts
Next >>